The Hill -- The Advanced Medical Technology Association (AdvaMed) this week raised concerns with a transparency task force’s recommendations regarding disclosures by the Food and Drug Administration. The trade association in particular warned that proposals to release more information before products are even approved and marketed would result in the release of trade secrets.
